Search research articles
Contact Us
Filters
Showing results (111-120 of 291) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer
Marion E Couch, Robert L Ferris, Joseph A Brennan, et al.
Cancer Discovery
|
December 23, 2020
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Oncoimmunology
|
September 14, 2020
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide
Adam C Mirando, Akash Patil, Christine I Rafie, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2003
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice
Matthew E Wolpoe, Eric R Lutz, Anne M Ercolini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2016
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation
Brian H Ladle, Kun-Po Li, Maggie J Phillips, et al.
Cancer Research
|
February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine
Xianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 25, 2014
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy
Katherine M Bever, Elizabeth A Sugar, Elaine Bigelow, et al.
The Journal of Cell Biology
|
July 10, 2020
Cancer cells educate natural killer cells to a metastasis-promoting cell state
Isaac S Chan, Hildur Knútsdóttir, Gayathri Ramakrishnan, et al.
Frontiers in Physiology
|
November 16, 2020
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
Haoyang Mi, Chang Gong, Jeremias Sulam, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy
Shuming Zhang, Hanwen Wang, Yeonju Cho, et al.
Page
of 30
Search research articles
Search
Showing results (111-120 of 291) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer
Marion E Couch, Robert L Ferris, Joseph A Brennan, et al.
Cancer Discovery
|
December 23, 2020
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Oncoimmunology
|
September 14, 2020
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide
Adam C Mirando, Akash Patil, Christine I Rafie, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2003
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice
Matthew E Wolpoe, Eric R Lutz, Anne M Ercolini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 2016
De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation
Brian H Ladle, Kun-Po Li, Maggie J Phillips, et al.
Cancer Research
|
February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine
Xianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 25, 2014
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy
Katherine M Bever, Elizabeth A Sugar, Elaine Bigelow, et al.
The Journal of Cell Biology
|
July 10, 2020
Cancer cells educate natural killer cells to a metastasis-promoting cell state
Isaac S Chan, Hildur Knútsdóttir, Gayathri Ramakrishnan, et al.
Frontiers in Physiology
|
November 16, 2020
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
Haoyang Mi, Chang Gong, Jeremias Sulam, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy
Shuming Zhang, Hanwen Wang, Yeonju Cho, et al.
Page
of 30